Prostate cancer therapies.
- Published in:
- Formulary, 1999, v. 34, n. 8, p. 712
- Publication type:
- Article
Works matching IS 1082801X AND DT 1999 AND VI 34 AND IP 8
Results: 21
1
2
Clinton calls for PBMs to administer universal Medicare drug benefit.
- Published in:
- Formulary, 1999, v. 34, n. 8, p. 711
- By:
- Publication type:
- Article
3
Improving the appropriate use of vancomycin: One facility's success with an order form.
- Published in:
- Formulary, 1999, v. 34, n. 8, p. 710
- Publication type:
- Article
4
Suggestions for adding alternative medicines to an OTC formulary of a managed care organization.
- Published in:
- Formulary, 1999, v. 34, n. 8, p. 704
- Publication type:
- Article
5
Sedation monitoring service reduces costs, cuts duration of ventilation and ICU stay.
- Published in:
- Formulary, 1999, v. 34, n. 8, p. 708
- Publication type:
- Article
6
Restricting use of broad-spectrum antibiotics an effective strategy in reducing resistant pathogens.
- Published in:
- Formulary, 1999, v. 34, n. 8, p. 704
- Publication type:
- Article
7
Helicobacter pylori: Diagnosis and treatment update.
- Published in:
- Formulary, 1999, v. 34, n. 8, p. 645
- By:
- Publication type:
- Article
8
Top cost-driving drug categories identified.
- Published in:
- Formulary, 1999, v. 34, n. 8, p. 644
- Publication type:
- Article
9
Critical evaluation of a decision-analytic model of major depression treatment.
- Published in:
- Formulary, 1999, v. 34, n. 8, p. 664
- By:
- Publication type:
- Article
10
Antibiotic resistance: Myths, truths, and a rational formulary approach.
- Published in:
- 1999
- By:
- Publication type:
- Interview
11
Another agent for IBS in late-stage development.
- Published in:
- Formulary, 1999, v. 34, n. 8, p. 642
- Publication type:
- Article
12
Revising the formulary review process: Use of a standardized document for manufacturers.
- Published in:
- Formulary, 1999, v. 34, n. 8, p. 688
- Publication type:
- Article
13
Experience with a decentralized IV to PO ofloxacin conversion program.
- Published in:
- Formulary, 1999, v. 34, n. 8, p. 683
- By:
- Publication type:
- Article
14
Higher drug copays may threaten optimal utilization.
- Published in:
- Formulary, 1999, v. 34, n. 8, p. 644
- Publication type:
- Article
15
Low-dose estrogen offers adequate bone-sparing effects in elderly women.
- Published in:
- Formulary, 1999, v. 34, n. 8, p. 644
- Publication type:
- Article
16
Ebastine.
- Published in:
- Formulary, 1999, v. 34, n. 8, p. 644
- By:
- Publication type:
- Article
17
5-HT[sub 3] receptor antagonist relieves multiple symptoms of irritable bowel syndrome.
- Published in:
- Formulary, 1999, v. 34, n. 8, p. 642
- Publication type:
- Article
18
Savings from generics are vastly underappreciated by MCOs, says managed pharmacy expert.
- Published in:
- 1999
- Publication type:
- Interview
19
New antihypertensive class promises superior reduction of systolic pressure.
- Published in:
- Formulary, 1999, v. 34, n. 8, p. 641
- Publication type:
- Article
20
FDA drug approvals.
- Published in:
- Formulary, 1999, v. 34, n. 8, p. 634
- Publication type:
- Article
21
Imitrex maintains dominance of triptan class, Diovan makes gains on Cozaar among ARBs.
- Published in:
- Formulary, 1999, v. 34, n. 8, p. 632
- Publication type:
- Article